Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Michael Fox International (MFI) was a prominent global asset management and industrial auctioneering firm that specialized in the pharmaceutical and biotechnology sectors. Founded in 1946 and headquartered in Baltimore, the company became a leading authority in the valuation and disposition of specialized laboratory equipment and pharmaceutical manufacturing facilities. MFI played a crucial role in the life sciences industry during the 1990s, managing the liquidation of assets for major corporations such as Hoechst Marion Roussel and Genetics Institute. The firm's expertise allowed for the efficient redistribution of high-tech assets within the research and development community. In 2000, Michael Fox International was acquired by GoIndustry, a move that integrated its specialized services into a larger global platform for surplus asset management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Michael Fox International.